+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

  • PDF Icon

    Report

  • 68 Pages
  • January 2022
  • Region: Global
  • Transparency Market Research
  • ID: 5568135
This report on the global continuous glucose monitoring market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides the overall revenue of the global continuous glucose monitoring market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global continuous glucose monitoring market for the forecast period.



The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global continuous glucose monitoring market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global continuous glucose monitoring market.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global continuous glucose monitoring market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global continuous glucose monitoring market. The next section of the continuous glucose monitoring market report highlights the USPs, which include COVID-19 pandemic impact on industry (value chain and short/mid/long term impact), prevalence and incidence rate of diabetes across the globe, technological advancements, pricing analysis, and overview of point-of-care testing.

The report delves into the competition landscape of the global continuous glucose monitoring market. Key players operating in the global continuous glucose monitoring market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global continuous glucose monitoring market in report.

Key Questions Answered in Continuous Glucose Monitoring Market Report

  • What are the sales/revenue generated by continuous glucose monitoring devices during the forecast period?
  • What are the key trends in the global continuous glucose monitoring market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which segment will have the highest revenue by 2028 and which segment will grow at the highest CAGR during the forecast period?

Strengths and weaknesses of major players

Competitive analysis of major players (2020)

Continuous Glucose Monitoring Market - Research Objectives and Research Approach

The comprehensive report on the global continuous glucose monitoring market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and health care compliances laid down by accredited agencies in the purview of research in the global continuous glucose monitoring market. It is followed by market introduction, market dynamics, and an overview of the global continuous glucose monitoring market, which includes analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global continuous glucose monitoring market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by prominent manufacturers has been mapped to ascertain the size of the global continuous glucose monitoring market in terms of value. The forecast presented here assesses the total revenue generated in the global continuous glucose monitoring market. In order to provide an accurate forecast, we initiated by sizing up the current global continuous glucose monitoring market with the help of the parent market.

The report analyzes the global continuous glucose monitoring market in terms of device/brand and country/sub-region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2028 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global continuous glucose monitoring market.
Frequently Asked Questions about the Continuous Glucose Monitoring Market

What is the estimated value of the Continuous Glucose Monitoring Market?

The Continuous Glucose Monitoring Market was estimated to be valued at $992.8 Million in 2021.

What is the growth rate of the Continuous Glucose Monitoring Market?

The growth rate of the Continuous Glucose Monitoring Market is 9.5%, with an estimated value of $2065.5 Million by 2028.

What is the forecasted size of the Continuous Glucose Monitoring Market?

The Continuous Glucose Monitoring Market is estimated to be worth $2065.5 Million by 2028.

Who are the key companies in the Continuous Glucose Monitoring Market?

Key companies in the Continuous Glucose Monitoring Market include Abbott, Bayer AG, Dexcom, Inc., Glysens Incorporated, Insulet Corporation, Medtronic, Nova Biomedical Corporation, Senseonics Incorporated, Livongo and BeatO.

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology3. Executive Summary: Global Continuous Glucose Monitoring Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Continuous Glucose Monitoring Market Analysis and Forecast, 2017-2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Prevalence & Incidence rate of Diabetes across globe
5.3. Pricing Analysis of devices
5.4. Overview of Point-of-care Testing
5.5. COVID-19 pandemic impact on Global Continuous Glucose Monitoring Market
6. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Device/Brand
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
6.3.1. Guardian Real Time CGM System
6.3.2. FreeStyle Navigator
6.3.3. Dexcom Seven Plus CGM System
6.3.4. Dexcom G4 Platinum
6.3.5. MiniMed Paradigm Revel/Veo Systems
6.3.6. Others
6.4. Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand,2021-2028
7. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Country/Sub-region
7.1. Key Findings
7.2. Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/Region,2017-2028
8. North America Continuous Glucose Monitoring Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
8.2.1. Guardian Real Time CGM System
8.2.2. FreeStyle Navigator
8.2.3. Dexcom Seven Plus CGM System
8.2.4. Dexcom G4 Platinum
8.2.5. MiniMed Paradigm Revel/Veo Systems
8.2.6. Others
8.3. North America Continuous Glucose Monitoring Market Analysis, by Country, 2017-2028
8.3.1. U.S.
8.3.2. Canada
8.4. North America Continuous Glucose Monitoring Market Attractiveness Analysis, 2021-2028
8.4.1. By Device/Brand
8.4.2. By Country/Sub-region
9. Europe Continuous Glucose Monitoring Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
9.2.1. Guardian Real Time CGM System
9.2.2. FreeStyle Navigator
9.2.3. Dexcom Seven Plus CGM System
9.2.4. Dexcom G4 Platinum
9.2.5. MiniMed Paradigm Revel/Veo Systems
9.2.6. Others
9.3. Europe Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017-2028
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Europe Continuous Glucose Monitoring Market Attractiveness Analysis, 2021-2028
9.4.1. By Device/Brand
9.4.2. By Country/Sub-region
10. Asia Pacific Continuous Glucose Monitoring Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
10.2.1. Guardian Real Time CGM System
10.2.2. FreeStyle Navigator
10.2.3. Dexcom Seven Plus CGM System
10.2.4. Dexcom G4 Platinum
10.2.5. MiniMed Paradigm Revel/Veo Systems
10.3. Asia Pacific Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017-2028
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, 2021-2028
10.4.1. By Device/Brand
10.4.2. By Country/Sub-region
11. Latin America Continuous Glucose Monitoring Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
11.2.1. Guardian Real Time CGM System
11.2.2. FreeStyle Navigator
11.2.3. Dexcom Seven Plus CGM System
11.2.4. Dexcom G4 Platinum
11.2.5. MiniMed Paradigm Revel/Veo Systems
11.3. Latin America Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017-2028
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, 2021-2028
11.4.1. By Device/Brand
11.4.2. By Country/Sub-region
12. Middle East & Africa Continuous Glucose Monitoring Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017-2028
12.2.1. Guardian Real Time CGM System
12.2.2. FreeStyle Navigator
12.2.3. Dexcom Seven Plus CGM System
12.2.4. Dexcom G4 Platinum
12.2.5. MiniMed Paradigm Revel/Veo Systems
12.3. Middle East & Africa Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017-2028
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, 2021-2028
12.4.1. By Device/Brand
12.4.2. By Country/Sub-region
13. Competitive Landscape
13.1. Company Profiles (2020)
13.1.1. Abbott
13.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.1.2. Product Portfolio
13.1.1.3. Financial Overview
13.1.1.4. Strategic Overview
13.1.1.5. SWOT Analysis
13.1.2. Bayer AG
13.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.2.2. Product Portfolio
13.1.2.3. Financial Overview
13.1.2.4. Strategic Overview
13.1.2.5. SWOT Analysis
13.1.3. Dexcom, Inc.
13.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.3.2. Product Portfolio
13.1.3.3. Financial Overview
13.1.3.4. Strategic Overview
13.1.3.5. SWOT Analysis
13.1.4. Glysens Incorporated
13.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.4.2. Product Portfolio
13.1.4.3. Strategic Overview
13.1.4.4. SWOT Analysis
13.1.5. Insulet Corporation
13.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.5.2. Product Portfolio
13.1.5.3. Financial Overview
13.1.5.4. Strategic Overview
13.1.5.5. SWOT Analysis
13.1.6. Medtronic
13.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.6.2. Product Portfolio
13.1.6.3. Financial Overview
13.1.6.4. Strategic Overview
13.1.6.5. SWOT Analysis
13.1.7. Nova Biomedical Corporation
13.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.7.2. Product Portfolio
13.1.7.3. Financial Overview
13.1.7.4. Strategic Overview
13.1.7.5. SWOT Analysis
13.1.8. Senseonics Incorporated
13.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.8.2. Product Portfolio
13.1.8.3. Strategic Overview
13.1.8.4. SWOT Analysis
13.1.9. Livongo
13.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.9.2. Product Portfolio
13.1.9.3. Strategic Overview
13.1.9.4. SWOT Analysis
13.1.10. BeatO
13.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.10.2. Product Portfolio
13.1.10.3. Strategic Overview
13.1.10.4. SWOT Analysis
13.1.11. Jana Care
13.1.11.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.11.2. Product Portfolio
13.1.11.3. Strategic Overview
13.1.11.4. SWOT Analysis
13.1.12. iXensor
13.1.12.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.12.2. Product Portfolio
13.1.12.3. Strategic Overview
13.1.12.4. SWOT Analysis
13.1.13. DiaMonTech AG
13.1.13.1. Company Overview (HQ, Business Segments, Employee Strength)
13.1.13.2. Product Portfolio
13.1.13.3. Financial Overview
13.1.13.4. Strategic Overview
13.1.13.5. SWOT Analysis

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott
  • Bayer AG
  • Dexcom, Inc.
  • Glysens Incorporated
  • Insulet Corporation
  • Medtronic
  • Nova Biomedical Corporation
  • Senseonics Incorporated
  • Livongo
  • BeatO
  • Jana Care
  • iXensor
  • DiaMonTech AG